New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
09:26 EDTNAVBNavidea price target lowered to $3 from $5 at JMP Securities
JMP Securities cut its price target on Navidea after the company announced that it plans to wind down its development of drug candidates for Alzheimerís and Parkinsonís diseases and focus on its launch of Lymphoseek. The firm keeps an Outperform rating.
News For NAVB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
07:50 EDTNAVBMacrophage says preclinical KS results show Manocept drug induces apoptosis
Subscribe for More Information
07:32 EDTNAVBNavidea says data demonstrate Manocept agent localizes in multiple KS lesions
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use